NCT03363217 2023-11-27Trametinib for Pediatric Neuro-oncology Patients With Refractory Tumor and Activation of the MAPK/ERK Pathway.St. Justine's HospitalPhase 2 Active not recruiting114 enrolled
NCT03820778 2021-03-02Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1Children's National Research InstitutePhase NA Active not recruiting10 enrolled